Skip to main content
logo
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.72
+0.05 (0.75%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Eupraxia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-50.21-38.58-25.5-28.22-18.49-18.93
Depreciation & Amortization
0.360.240.170.160.150.09
Loss (Gain) From Sale of Assets
00-0.0200.01-
Stock-Based Compensation
11.438.763.221.411.432.71
Other Operating Activities
-4.711.74-1.10.550.994.72
Change in Accounts Receivable
-0.54-0.43-0.1-0.10.230.15
Change in Accounts Payable
5.812.36-0.710.581.32-0.5
Change in Other Net Operating Assets
0.38-2.64-5.954.88-0.040.05
Operating Cash Flow
-37.47-28.55-29.99-20.75-14.4-11.72
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.75-0.59-0.1-0.07-0.24-0.34
Sale of Property, Plant & Equipment
--0.03-0-
Investment in Securities
-79.72---10.07-7.11
Other Investing Activities
------3.97
Investing Cash Flow
-80.48-0.59-0.08-0.079.83-11.42

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----0.08
Long-Term Debt Issued
-----10.08
Total Debt Issued
-----10.16
Long-Term Debt Repaid
---9.14-0.08-0.14-0.46
Net Debt Issued (Repaid)
---9.14-0.08-0.149.69
Issuance of Common Stock
151.4576.0654.9221.1610.9429.9
Financing Cash Flow
151.4576.0645.7821.0810.839.59

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.840.54-1.960.82-0.51-0.06
Net Cash Flow
32.6647.4613.761.085.7316.39

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-38.23-29.14-30.1-20.82-14.63-12.06
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.72-0.73-0.89-0.86-0.76-0.97
Levered Free Cash Flow
-24.21-16.3-20.95-10.78-8.72-12.98
Unlevered Free Cash Flow
-24.21-16.3-20.35-10.05-8.11-12.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--0.390.60.330.46
Change in Working Capital
5.65-0.71-6.765.351.51-0.3
SEC Filings: 10-K · 10-Q